Ameriprise Financial Inc Protagonist Therapeutics, Inc Transaction History

Ameriprise Financial Inc

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2023 Aug 14, 2023	BUY	$18.02 - $29.36 $1.47 Million - $2.39 Million	81,572 Added 444.34%	99,930 $2.76 Million
Q1 2023 May 15, 2023	BUY	$10.78 - $25.38 $197,899 - $465,926	18,358 New	18,358 $422,000
Q2 2021 Aug 16, 2021	SELL	$25.57 - $44.88 $728,438 - $1.28 Million	-28,488 Closed	0 $0
Q1 2021 May 17, 2021	SELL	$19.02 - $31.15 $729,740 - $1.2 Million	-38,367 Reduced 57.39%	28,488 $737,000
Q4 2020 Feb 12, 2021	BUY	$18.49 - $25.13 $1.24 Million - $1.68 Million	66,855 New	66,855 $1.35 Million

212

59.1M

19K

107K

Ticker PTGX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 49,084,100
Market Cap $2.25B
Description
Protagonist Therapeutics, Inc., a biopharmaceutical company, discovers and develops peptide-based therapeutic drugs to address hematology and blood disorders, and inflammatory and immunomodulatory diseases. It is developing rusfertide (PTG-300), an injectable hepcidin mimetic that is in Phase II clinical trials for the treatment of patients with...

Get notified when there are updates to the investment portfolio of Ameriprise Financial Inc, based on Form 13F filings with the SEC.

Stay updated on Ameriprise Financial Inc with notifications on news.